Non-therapeutic antibiotics are administered at sub therapeutic levels in order to increase feed conversion rate. In order to have better margins livestock farmers administer the antibiotics in very low quantity through water especially in poultry and swine. Compound feed manufacturers and feed premix manufacturers are also adding antibiotics to make sure, their feed and ingredients give maximum profit to its buyers. However, such practice has led to development of antibiotic resistant pathogens and hence are being banned in many countries and also controversy on its uses are increasing progressively. Thus the growth of antibiotics in many countries are being plateaued out and in others growth may prematurely can plateaued or even drastically fall.
The global Non-Therapeutic Antibiotics for Food Animals market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 20%.
This report aims to provide a comprehensive presentation of the global market for Non-Therapeutic Antibiotics for Food Animals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-Therapeutic Antibiotics for Food Animals.
Report Scope
The Non-Therapeutic Antibiotics for Food Animals market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Non-Therapeutic Antibiotics for Food Animals market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Non-Therapeutic Antibiotics for Food Animals manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AG Zoetis, Inc.
Boehringer Ingelheim GmbH
Eli Lilly and Company
Merck & Co., Inc.
Bayer AG
AG Sanofi
Ceva Sante Animale
Virbac
Vetoquinol S.A.
Dechra Pharmaceuticals
Segment by Type
Oxytetracyclines
Tylosin
Ampicillin and Amoxycillin
Gentamicin
Sulfaquinoxaline
Salinomycin
Bacitracin
Others
Segment by Application
Cattle Feed
Poultry Feed
Swine Feed
Aqua Feed
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Non-Therapeutic Antibiotics for Food Animals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Non-Therapeutic Antibiotics for Food Animals in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Non-Therapeutic Antibiotics for Food Animals Market Overview
1.1 Product Overview and Scope of Non-Therapeutic Antibiotics for Food Animals
1.2 Non-Therapeutic Antibiotics for Food Animals Segment by Type
1.2.1 Global Non-Therapeutic Antibiotics for Food Animals Market Value Comparison by Type (2024-2030)
1.2.2 Oxytetracyclines
1.2.3 Tylosin
1.2.4 Ampicillin and Amoxycillin
1.2.5 Gentamicin
1.2.6 Sulfaquinoxaline
1.2.7 Salinomycin
1.2.8 Bacitracin
1.2.9 Others
1.3 Non-Therapeutic Antibiotics for Food Animals Segment by Application
1.3.1 Global Non-Therapeutic Antibiotics for Food Animals Market Value by Application: (2024-2030)
1.3.2 Cattle Feed
1.3.3 Poultry Feed
1.3.4 Swine Feed
1.3.5 Aqua Feed
1.3.6 Others
1.4 Global Non-Therapeutic Antibiotics for Food Animals Market Size Estimates and Forecasts
1.4.1 Global Non-Therapeutic Antibiotics for Food Animals Revenue 2019-2030
1.4.2 Global Non-Therapeutic Antibiotics for Food Animals Sales 2019-2030
1.4.3 Global Non-Therapeutic Antibiotics for Food Animals Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Non-Therapeutic Antibiotics for Food Animals Market Competition by Manufacturers
2.1 Global Non-Therapeutic Antibiotics for Food Animals Sales Market Share by Manufacturers (2019-2024)
2.2 Global Non-Therapeutic Antibiotics for Food Animals Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Non-Therapeutic Antibiotics for Food Animals Average Price by Manufacturers (2019-2024)
2.4 Global Non-Therapeutic Antibiotics for Food Animals Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Non-Therapeutic Antibiotics for Food Animals, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Non-Therapeutic Antibiotics for Food Animals, Product Type & Application
2.7 Non-Therapeutic Antibiotics for Food Animals Market Competitive Situation and Trends
2.7.1 Non-Therapeutic Antibiotics for Food Animals Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Non-Therapeutic Antibiotics for Food Animals Players Market Share by Revenue
2.7.3 Global Non-Therapeutic Antibiotics for Food Animals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Non-Therapeutic Antibiotics for Food Animals Retrospective Market Scenario by Region
3.1 Global Non-Therapeutic Antibiotics for Food Animals Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Non-Therapeutic Antibiotics for Food Animals Global Non-Therapeutic Antibiotics for Food Animals Sales by Region: 2019-2030
3.2.1 Global Non-Therapeutic Antibiotics for Food Animals Sales by Region: 2019-2024
3.2.2 Global Non-Therapeutic Antibiotics for Food Animals Sales by Region: 2025-2030
3.3 Global Non-Therapeutic Antibiotics for Food Animals Global Non-Therapeutic Antibiotics for Food Animals Revenue by Region: 2019-2030
3.3.1 Global Non-Therapeutic Antibiotics for Food Animals Revenue by Region: 2019-2024
3.3.2 Global Non-Therapeutic Antibiotics for Food Animals Revenue by Region: 2025-2030
3.4 North America Non-Therapeutic Antibiotics for Food Animals Market Facts & Figures by Country
3.4.1 North America Non-Therapeutic Antibiotics for Food Animals Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Non-Therapeutic Antibiotics for Food Animals Sales by Country (2019-2030)
3.4.3 North America Non-Therapeutic Antibiotics for Food Animals Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Non-Therapeutic Antibiotics for Food Animals Market Facts & Figures by Country
3.5.1 Europe Non-Therapeutic Antibiotics for Food Animals Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Non-Therapeutic Antibiotics for Food Animals Sales by Country (2019-2030)
3.5.3 Europe Non-Therapeutic Antibiotics for Food Animals Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Non-Therapeutic Antibiotics for Food Animals Market Facts & Figures by Country
3.6.1 Asia Pacific Non-Therapeutic Antibiotics for Food Animals Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Non-Therapeutic Antibiotics for Food Animals Sales by Country (2019-2030)
3.6.3 Asia Pacific Non-Therapeutic Antibiotics for Food Animals Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Non-Therapeutic Antibiotics for Food Animals Market Facts & Figures by Country
3.7.1 Latin America Non-Therapeutic Antibiotics for Food Animals Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Non-Therapeutic Antibiotics for Food Animals Sales by Country (2019-2030)
3.7.3 Latin America Non-Therapeutic Antibiotics for Food Animals Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Non-Therapeutic Antibiotics for Food Animals Market Facts & Figures by Country
3.8.1 Middle East and Africa Non-Therapeutic Antibiotics for Food Animals Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Non-Therapeutic Antibiotics for Food Animals Sales by Country (2019-2030)
3.8.3 Middle East and Africa Non-Therapeutic Antibiotics for Food Animals Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Non-Therapeutic Antibiotics for Food Animals Sales by Type (2019-2030)
4.1.1 Global Non-Therapeutic Antibiotics for Food Animals Sales by Type (2019-2024)
4.1.2 Global Non-Therapeutic Antibiotics for Food Animals Sales by Type (2025-2030)
4.1.3 Global Non-Therapeutic Antibiotics for Food Animals Sales Market Share by Type (2019-2030)
4.2 Global Non-Therapeutic Antibiotics for Food Animals Revenue by Type (2019-2030)
4.2.1 Global Non-Therapeutic Antibiotics for Food Animals Revenue by Type (2019-2024)
4.2.2 Global Non-Therapeutic Antibiotics for Food Animals Revenue by Type (2025-2030)
4.2.3 Global Non-Therapeutic Antibiotics for Food Animals Revenue Market Share by Type (2019-2030)
4.3 Global Non-Therapeutic Antibiotics for Food Animals Price by Type (2019-2030)
5 Segment by Application
5.1 Global Non-Therapeutic Antibiotics for Food Animals Sales by Application (2019-2030)
5.1.1 Global Non-Therapeutic Antibiotics for Food Animals Sales by Application (2019-2024)
5.1.2 Global Non-Therapeutic Antibiotics for Food Animals Sales by Application (2025-2030)
5.1.3 Global Non-Therapeutic Antibiotics for Food Animals Sales Market Share by Application (2019-2030)
5.2 Global Non-Therapeutic Antibiotics for Food Animals Revenue by Application (2019-2030)
5.2.1 Global Non-Therapeutic Antibiotics for Food Animals Revenue by Application (2019-2024)
5.2.2 Global Non-Therapeutic Antibiotics for Food Animals Revenue by Application (2025-2030)
5.2.3 Global Non-Therapeutic Antibiotics for Food Animals Revenue Market Share by Application (2019-2030)
5.3 Global Non-Therapeutic Antibiotics for Food Animals Price by Application (2019-2030)
6 Key Companies Profiled
6.1 AG Zoetis, Inc.
6.1.1 AG Zoetis, Inc. Corporation Information
6.1.2 AG Zoetis, Inc. Description and Business Overview
6.1.3 AG Zoetis, Inc. Non-Therapeutic Antibiotics for Food Animals Sales, Revenue and Gross Margin (2019-2024)
6.1.4 AG Zoetis, Inc. Non-Therapeutic Antibiotics for Food Animals Product Portfolio
6.1.5 AG Zoetis, Inc. Recent Developments/Updates
6.2 Boehringer Ingelheim GmbH
6.2.1 Boehringer Ingelheim GmbH Corporation Information
6.2.2 Boehringer Ingelheim GmbH Description and Business Overview
6.2.3 Boehringer Ingelheim GmbH Non-Therapeutic Antibiotics for Food Animals Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Boehringer Ingelheim GmbH Non-Therapeutic Antibiotics for Food Animals Product Portfolio
6.2.5 Boehringer Ingelheim GmbH Recent Developments/Updates
6.3 Eli Lilly and Company
6.3.1 Eli Lilly and Company Corporation Information
6.3.2 Eli Lilly and Company Description and Business Overview
6.3.3 Eli Lilly and Company Non-Therapeutic Antibiotics for Food Animals Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Eli Lilly and Company Non-Therapeutic Antibiotics for Food Animals Product Portfolio
6.3.5 Eli Lilly and Company Recent Developments/Updates
6.4 Merck & Co., Inc.
6.4.1 Merck & Co., Inc. Corporation Information
6.4.2 Merck & Co., Inc. Description and Business Overview
6.4.3 Merck & Co., Inc. Non-Therapeutic Antibiotics for Food Animals Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merck & Co., Inc. Non-Therapeutic Antibiotics for Food Animals Product Portfolio
6.4.5 Merck & Co., Inc. Recent Developments/Updates
6.5 Bayer AG
6.5.1 Bayer AG Corporation Information
6.5.2 Bayer AG Description and Business Overview
6.5.3 Bayer AG Non-Therapeutic Antibiotics for Food Animals Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Bayer AG Non-Therapeutic Antibiotics for Food Animals Product Portfolio
6.5.5 Bayer AG Recent Developments/Updates
6.6 AG Sanofi
6.6.1 AG Sanofi Corporation Information
6.6.2 AG Sanofi Description and Business Overview
6.6.3 AG Sanofi Non-Therapeutic Antibiotics for Food Animals Sales, Revenue and Gross Margin (2019-2024)
6.6.4 AG Sanofi Non-Therapeutic Antibiotics for Food Animals Product Portfolio
6.6.5 AG Sanofi Recent Developments/Updates
6.7 Ceva Sante Animale
6.6.1 Ceva Sante Animale Corporation Information
6.6.2 Ceva Sante Animale Description and Business Overview
6.6.3 Ceva Sante Animale Non-Therapeutic Antibiotics for Food Animals Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ceva Sante Animale Non-Therapeutic Antibiotics for Food Animals Product Portfolio
6.7.5 Ceva Sante Animale Recent Developments/Updates
6.8 Virbac
6.8.1 Virbac Corporation Information
6.8.2 Virbac Description and Business Overview
6.8.3 Virbac Non-Therapeutic Antibiotics for Food Animals Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Virbac Non-Therapeutic Antibiotics for Food Animals Product Portfolio
6.8.5 Virbac Recent Developments/Updates
6.9 Vetoquinol S.A.
6.9.1 Vetoquinol S.A. Corporation Information
6.9.2 Vetoquinol S.A. Description and Business Overview
6.9.3 Vetoquinol S.A. Non-Therapeutic Antibiotics for Food Animals Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Vetoquinol S.A. Non-Therapeutic Antibiotics for Food Animals Product Portfolio
6.9.5 Vetoquinol S.A. Recent Developments/Updates
6.10 Dechra Pharmaceuticals
6.10.1 Dechra Pharmaceuticals Corporation Information
6.10.2 Dechra Pharmaceuticals Description and Business Overview
6.10.3 Dechra Pharmaceuticals Non-Therapeutic Antibiotics for Food Animals Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Dechra Pharmaceuticals Non-Therapeutic Antibiotics for Food Animals Product Portfolio
6.10.5 Dechra Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Non-Therapeutic Antibiotics for Food Animals Industry Chain Analysis
7.2 Non-Therapeutic Antibiotics for Food Animals Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Non-Therapeutic Antibiotics for Food Animals Production Mode & Process
7.4 Non-Therapeutic Antibiotics for Food Animals Sales and Marketing
7.4.1 Non-Therapeutic Antibiotics for Food Animals Sales Channels
7.4.2 Non-Therapeutic Antibiotics for Food Animals Distributors
7.5 Non-Therapeutic Antibiotics for Food Animals Customers
8 Non-Therapeutic Antibiotics for Food Animals Market Dynamics
8.1 Non-Therapeutic Antibiotics for Food Animals Industry Trends
8.2 Non-Therapeutic Antibiotics for Food Animals Market Drivers
8.3 Non-Therapeutic Antibiotics for Food Animals Market Challenges
8.4 Non-Therapeutic Antibiotics for Food Animals Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
AG Zoetis, Inc.
Boehringer Ingelheim GmbH
Eli Lilly and Company
Merck & Co., Inc.
Bayer AG
AG Sanofi
Ceva Sante Animale
Virbac
Vetoquinol S.A.
Dechra Pharmaceuticals
*If Applicable.